Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Inupadenant, also known as EOS-850, is a highly selective small molecule antagonist of the adenosine A2a receptor, in the adenosine triphosphate adenosine pathway, a key driver of immunosuppression in the tumor microenvironment across a broad range of tumors.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 3,470.00 | |
50 mg | 10-14 weeks | $ 4,580.00 | |
100 mg | 10-14 weeks | $ 6,400.00 |
Description | Inupadenant, also known as EOS-850, is a highly selective small molecule antagonist of the adenosine A2a receptor, in the adenosine triphosphate adenosine pathway, a key driver of immunosuppression in the tumor microenvironment across a broad range of tumors. |
Molecular Weight | 641.1098 |
Formula | C25H27ClF2N8O4S2 |
CAS No. | 2411004-22-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Inupadenant HCl 2411004-22-1 NITD 688 NITD688 inhibitor inhibit